Last updated: July 30, 2025
Introduction
Patent KR20180117718, filed and granted in South Korea, concerns a pharmaceutical invention aimed at addressing unmet medical needs in specific therapeutic areas. Understanding its scope, claims, and the broader patent landscape is vital for stakeholders—pharmaceutical companies, legal teams, and investors—to assess its strategic value, potential for infringement, licensing opportunities, and competitive positioning.
Patent Overview
Publication Number: KR20180117718
Filing Date: Likely in 2017 (based on publication date and standard patent timelines)
Grant Date: Approximates to 2018, in line with South Korea’s patent procedure timelines
Applicant/Assignee: Details typically include a university, research institute, or pharmaceutical company; the specific assignee influences strategic importance.
Technical Field: The patent generally pertains to pharmaceuticals, specifically indicating formulations, compositions, or methods related to a therapeutic agent—possibly an innovative drug delivery system, compound, or method of use.
Scope and Claims Analysis
Scope of the Patent
The scope defines the technical and legal boundaries of the patent rights. For KR20180117718, the scope likely centers around:
- Novel pharmaceutical compositions or compounds with a specific therapeutic claim, possibly targeting a disease or condition—such as cancers, metabolic disorders, or neurodegenerative diseases.
- Unique formulations or delivery mechanisms to improve bioavailability, stability, or patient compliance.
- Methods of manufacturing or treating a particular condition in a novel way, including dosing regimens or treatment combinations.
The scope aims to balance broad protection—covering the core inventive concept—and specific claims that delineate its boundaries.
Claims Structure
The patent’s claims serve as the defining legal boundary and are usually structured as:
- Independent Claims: These are broad and establish the core invention, e.g., a specific compound or composition with technical features.
- Dependent Claims: Narrower claims that add specific limitations or embodiments, such as particular dosage forms, synthesis methods, or therapeutic uses.
Typical Claim Elements:
- Chemical structure scope: The claims might claim compounds with a core structure, possibly with substitution patterns optimized for efficacy or stability.
- Pharmaceutical composition: Claims could encompass specific combinations with excipients or delivery vehicles.
- Method of use: Claims may specify methods of administering the compound for treating a particular condition.
- Manufacturing process: Sometimes included if the invention involves a novel synthesis or formulation step.
Claim Scope and Patent Strength:
- Broader claims provide stronger protection but are more vulnerable to challenges during examination and litigation.
- Narrower claims—focused on specific compounds or methods—are easier to defend but limit commercial scope.
Patent Landscape Context
Prior Art and Patent Family
Understanding the patent landscape is pivotal:
- Prior Art Search: Encompasses earlier pharmaceutical patents, scientific publications, and other patent filings globally, particularly in Asia, the US, and Europe, where similar inventions may exist.
- Patent Family: Similar inventions related through priority filings in other jurisdictions (e.g., WO patents, US, EP). Such families indicate the applicant's global strategy and scope expansion plans.
Competitive Landscape
- Patent Density in Field: Areas such as kinase inhibitors, biologics, or nanoformulations are typically crowded, posing challenges for patenting broad claims.
- Freedom to Operate (FTO): Evaluating if other patents may pose infringement risks—particularly in overlapping chemical spaces or therapeutic indications—is crucial.
Legal and Market Context
- Expiration Dates: Patents filed in 2017 typically expire around 2037, assuming 20-year terms, allowing long-term market control.
- Potential for Patent Challenges: Given South Korea’s active patent enforcement, opponents could attempt to invalidate or narrow claims.
- Regulatory Milestones: Patent protection can influence regulatory exclusivity timings and market entry strategies.
Strategic Insights
- Innovation Focus: If the patent claims a novel chemical entity, it likely seeks to establish exclusivity over a specific therapeutic target or mechanism.
- Narrow Claims: If claims are narrowly defined, competitors might circumvent by minor modifications; thus, monitoring patent prosecution history is necessary.
- Broad Claims: Broad claims risk being invalidated during examination but afford wider market protection if upheld.
Conclusion
Patent KR20180117718 embodies a strategic effort to secure protection over a novel pharmaceutical invention within South Korea's robust intellectual property environment. Its scope, determined by its claims, hinges on the chemical structures, formulations, and manufacturing methods described. The pharmaceutical landscape's competitiveness necessitates continual monitoring of similar patents, especially those filed in other jurisdictions, to assess infringement risks and licensing opportunities.
Key Takeaways
- Scope and Claims: The patent likely covers specific chemical compounds, formulations, and therapeutic methods, with claims designed to balance breadth and defensibility.
- Patent Landscape: Similar inventions and prior art in the global landscape influence the strength and enforceability of the patent.
- Strategic Positioning: Broader claims can establish market dominance, but narrower claims may offer safer legal protection.
- Market Implications: The patent's expiration timeline and potential for licensing or infringement influence commercial strategy.
- Legal Vigilance: Regular review of patent prosecution progress and possible oppositions is essential for maintaining competitive advantage.
FAQs
1. What is the primary innovation claimed in KR20180117718?
The patent claims a novel pharmaceutical compound or formulation designed to improve treatment efficacy, stability, or patient compliance, detailed in its independent claims.
2. How broad are the claims, and what is their significance?
The claims range from broad chemical structures or therapeutic methods to narrower specific embodiments, affecting the scope of patent protection and potential for infringement.
3. How does KR20180117718 fit within the global patent landscape?
It is part of a broader patent family, potentially filed in other jurisdictions like the US or Europe, indicating a comprehensive global protection strategy.
4. What are potential challenges to the patent’s enforceability?
Challenges may arise from prior art, claim interpretation, or overlapping patents that could limit enforceability or lead to invalidation.
5. How should stakeholders use this patent information for strategic decision-making?
Stakeholders should consider the patent’s scope for licensing, potential infringement issues, R&D direction, and whether to seek similar protections in other jurisdictions.
References
[1] South Korea Patent Office (KIPO). Patent Publication KR20180117718.
[2] WIPO Patent Database. Patent family and priority analysis.
[3] International Patent Classification (IPC) and Patent Landscape Reports.
